ALI in Cancer Patients
ALI
Outcomes of Acute Limb Ischemia in Cancer Patients .
1 other identifier
observational
40
0 countries
N/A
Brief Summary
The aim of the study is to describe and evaluate the outcomes of cancer patients presenting with and treated for ALI at our center .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2025
CompletedFirst Posted
Study publicly available on registry
March 18, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
CompletedMarch 18, 2025
March 1, 2025
1 year
March 12, 2025
March 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Limb Salvage
baseline
Eligibility Criteria
Cancer patients .
You may qualify if:
- All cancer patient presented to Vascular and Endovascular surgery departement with ALI.
You may not qualify if:
- Patients with benign tumors or without active malignancy.
- Patients with iatrogenic limb ischemia related to a tumor chemoembolization procedure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident .
Study Record Dates
First Submitted
March 12, 2025
First Posted
March 18, 2025
Study Start
May 1, 2025
Primary Completion
May 1, 2026
Study Completion
July 1, 2026
Last Updated
March 18, 2025
Record last verified: 2025-03